BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

D609

tricyclodecane-9-yl-xanthogenate [Supplementary Concept]

49+ PubMed studies analyzed · Evidence Score: 32.5

Research Domains

D609 has been studied across 16 research domains including 🔬 Oncology, 🔬 Inflammation, 🔥 Metabolic, ⚡ Energy & Fatigue, 🧠 Neuroprotection. The primary research focus is 🔬 Oncology with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with D609, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

acetylsulfanilamide
4 shared targets
4
4 shared targets
3
4 shared targets
4
3 shared targets
7
3 shared targets
bicarbonate
3 shared targets
phenylsulfamate
3 shared targets
cyanate
3 shared targets
slc
4 shared targets
methylparaben
4 shared targets
Loading evidence profile...

This evidence profile for D609 is generated deterministically from 49 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.